【4502】武田薬

R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(5/5)
2019-11-14(20:00)

関連タグ:








OX2R AGONISTS FOR THE TREATMENT OF NARCOLEPSY TYPE 1
Deborah Hartman, PhD
Global Program Leader, Neuroscience Takeda Pharmaceutical Company Limited New York, NY November 14, 2019

NARCOLEPSY TYPE 1 IS A RARE, ACQUIRED CHRONIC NEUROLOGICAL DISORDER

3M
Estimated global population affected by NT11

~50%
Estimated diagnostic rate for NT1 in US, EU, JP2

15Y

Mean diagnostic delay3 When I'm awake, sleep is constantly intruding on that part of my life. And when I'm asleep, wakefulness is constantly intruding on that part of my life. It's frustrating because no matter how well you regulate your nar
				

関連タグ:



  R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(5/5)






日付 始値 高値 安値 終値 出来高
2019-11-14 4399 4438 4358 4372 5840500
2019-11-13 4307 4382 4275 4370 5678400
2019-11-12 4300 4332 4263 4303 3946200
2019-11-11 4400 4406 4304 4319 5328300
2019-11-08 4320 4390 4309 4378 9588600
2019-11-07 4266 4299 4231 4278 6494500
2019-11-06 4197 4227 4152 4227 6623300
2019-11-05 4070 4213 4061 4204 10314400

関連情報
曜日別開示状況
年月